nodes	percent_of_prediction	percent_of_DWPC	metapath
Clemastine—CYP3A4—prostate cancer	0.274	1	CbGaD
Clemastine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0783	0.154	CbGbCtD
Clemastine—CYP2D6—Bicalutamide—prostate cancer	0.0646	0.128	CbGbCtD
Clemastine—CYP2D6—Abiraterone—prostate cancer	0.0536	0.106	CbGbCtD
Clemastine—CYP3A4—Bicalutamide—prostate cancer	0.0411	0.0811	CbGbCtD
Clemastine—CYP3A4—Estramustine—prostate cancer	0.0382	0.0754	CbGbCtD
Clemastine—CYP3A4—Flutamide—prostate cancer	0.0341	0.0672	CbGbCtD
Clemastine—CYP3A4—Abiraterone—prostate cancer	0.0341	0.0672	CbGbCtD
Clemastine—CYP3A4—Cabazitaxel—prostate cancer	0.0252	0.0497	CbGbCtD
Clemastine—CYP3A4—Estrone—prostate cancer	0.0246	0.0486	CbGbCtD
Clemastine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0219	0.0433	CbGbCtD
Clemastine—CYP3A4—Conjugated Estrogens—prostate cancer	0.0161	0.0318	CbGbCtD
Clemastine—CYP3A4—Mitoxantrone—prostate cancer	0.0146	0.0289	CbGbCtD
Clemastine—CYP3A4—Estradiol—prostate cancer	0.0141	0.0279	CbGbCtD
Clemastine—CYP3A4—Prednisone—prostate cancer	0.0122	0.024	CbGbCtD
Clemastine—CYP2D6—Doxorubicin—prostate cancer	0.00991	0.0196	CbGbCtD
Clemastine—CYP3A4—Etoposide—prostate cancer	0.00923	0.0182	CbGbCtD
Clemastine—CYP3A4—Docetaxel—prostate cancer	0.00845	0.0167	CbGbCtD
Clemastine—CYP3A4—Doxorubicin—prostate cancer	0.0063	0.0124	CbGbCtD
Clemastine—Eletriptan—CYP2A6—prostate cancer	0.000375	0.14	CrCbGaD
Clemastine—Azelastine—CYP3A5—prostate cancer	0.000336	0.126	CrCbGaD
Clemastine—Azelastine—CYP2A6—prostate cancer	0.000325	0.122	CrCbGaD
Clemastine—Agranulocytosis—Etoposide—prostate cancer	0.000288	0.00189	CcSEcCtD
Clemastine—Paraesthesia—Goserelin—prostate cancer	0.000287	0.00189	CcSEcCtD
Clemastine—Insomnia—Conjugated Estrogens—prostate cancer	0.000287	0.00189	CcSEcCtD
Clemastine—Agitation—Estradiol—prostate cancer	0.000286	0.00188	CcSEcCtD
Clemastine—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000285	0.00187	CcSEcCtD
Clemastine—Somnolence—Goserelin—prostate cancer	0.000284	0.00187	CcSEcCtD
Clemastine—Somnolence—Conjugated Estrogens—prostate cancer	0.000282	0.00185	CcSEcCtD
Clemastine—Dyspepsia—Goserelin—prostate cancer	0.000282	0.00185	CcSEcCtD
Clemastine—Vertigo—Estradiol—prostate cancer	0.000279	0.00184	CcSEcCtD
Clemastine—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000279	0.00184	CcSEcCtD
Clemastine—Asthenia—Ethinyl Estradiol—prostate cancer	0.000279	0.00184	CcSEcCtD
Clemastine—Decreased appetite—Goserelin—prostate cancer	0.000278	0.00183	CcSEcCtD
Clemastine—Fatigue—Goserelin—prostate cancer	0.000276	0.00182	CcSEcCtD
Clemastine—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000275	0.00181	CcSEcCtD
Clemastine—Palpitations—Estradiol—prostate cancer	0.000275	0.00181	CcSEcCtD
Clemastine—Irritability—Prednisone—prostate cancer	0.000274	0.0018	CcSEcCtD
Clemastine—Constipation—Goserelin—prostate cancer	0.000274	0.0018	CcSEcCtD
Clemastine—Fatigue—Conjugated Estrogens—prostate cancer	0.000273	0.0018	CcSEcCtD
Clemastine—Nausea—Bicalutamide—prostate cancer	0.000273	0.0018	CcSEcCtD
Clemastine—Vision blurred—Mitoxantrone—prostate cancer	0.000273	0.0018	CcSEcCtD
Clemastine—Constipation—Conjugated Estrogens—prostate cancer	0.000271	0.00178	CcSEcCtD
Clemastine—Sweating increased—Capecitabine—prostate cancer	0.000271	0.00178	CcSEcCtD
Clemastine—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000266	0.00175	CcSEcCtD
Clemastine—Feeling abnormal—Goserelin—prostate cancer	0.000264	0.00174	CcSEcCtD
Clemastine—Eletriptan—CYP2C19—prostate cancer	0.000264	0.0986	CrCbGaD
Clemastine—Dizziness—Ethinyl Estradiol—prostate cancer	0.000257	0.00169	CcSEcCtD
Clemastine—Confusional state—Estradiol—prostate cancer	0.000256	0.00168	CcSEcCtD
Clemastine—Photosensitivity—Epirubicin—prostate cancer	0.000255	0.00168	CcSEcCtD
Clemastine—Photosensitivity reaction—Capecitabine—prostate cancer	0.000254	0.00167	CcSEcCtD
Clemastine—Anaphylactic shock—Estradiol—prostate cancer	0.000254	0.00167	CcSEcCtD
Clemastine—Neuropathy peripheral—Docetaxel—prostate cancer	0.000251	0.00165	CcSEcCtD
Clemastine—Convulsion—Mitoxantrone—prostate cancer	0.000251	0.00165	CcSEcCtD
Clemastine—Chills—Etoposide—prostate cancer	0.000248	0.00163	CcSEcCtD
Clemastine—Tachycardia—Estradiol—prostate cancer	0.000247	0.00163	CcSEcCtD
Clemastine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000247	0.00163	CcSEcCtD
Clemastine—Hyperhidrosis—Estradiol—prostate cancer	0.000245	0.00161	CcSEcCtD
Clemastine—Headache—Ethinyl Estradiol—prostate cancer	0.000243	0.0016	CcSEcCtD
Clemastine—Neuropathy peripheral—Capecitabine—prostate cancer	0.000243	0.0016	CcSEcCtD
Clemastine—Sweating increased—Prednisone—prostate cancer	0.000241	0.00159	CcSEcCtD
Clemastine—Agranulocytosis—Docetaxel—prostate cancer	0.000239	0.00157	CcSEcCtD
Clemastine—Confusional state—Mitoxantrone—prostate cancer	0.000238	0.00157	CcSEcCtD
Clemastine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000236	0.00156	CcSEcCtD
Clemastine—Photosensitivity—Doxorubicin—prostate cancer	0.000236	0.00155	CcSEcCtD
Clemastine—Agranulocytosis—Capecitabine—prostate cancer	0.000231	0.00152	CcSEcCtD
Clemastine—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000231	0.00152	CcSEcCtD
Clemastine—Nausea—Ethinyl Estradiol—prostate cancer	0.000231	0.00152	CcSEcCtD
Clemastine—Azelastine—CYP2E1—prostate cancer	0.000231	0.0863	CrCbGaD
Clemastine—Tachycardia—Mitoxantrone—prostate cancer	0.000231	0.00152	CcSEcCtD
Clemastine—Asthenia—Goserelin—prostate cancer	0.00023	0.00151	CcSEcCtD
Clemastine—Insomnia—Estradiol—prostate cancer	0.000229	0.00151	CcSEcCtD
Clemastine—Azelastine—CYP2C19—prostate cancer	0.000228	0.0855	CrCbGaD
Clemastine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000228	0.0015	CcSEcCtD
Clemastine—Paraesthesia—Estradiol—prostate cancer	0.000228	0.0015	CcSEcCtD
Clemastine—Azelastine—CYP1A1—prostate cancer	0.000228	0.0851	CrCbGaD
Clemastine—Asthenia—Conjugated Estrogens—prostate cancer	0.000227	0.0015	CcSEcCtD
Clemastine—Somnolence—Estradiol—prostate cancer	0.000225	0.00148	CcSEcCtD
Clemastine—Anorexia—Mitoxantrone—prostate cancer	0.000225	0.00148	CcSEcCtD
Clemastine—Diplopia—Epirubicin—prostate cancer	0.000224	0.00148	CcSEcCtD
Clemastine—Dyspepsia—Estradiol—prostate cancer	0.000223	0.00147	CcSEcCtD
Clemastine—Hypotension—Mitoxantrone—prostate cancer	0.000221	0.00145	CcSEcCtD
Clemastine—Decreased appetite—Estradiol—prostate cancer	0.00022	0.00145	CcSEcCtD
Clemastine—Diarrhoea—Goserelin—prostate cancer	0.000219	0.00144	CcSEcCtD
Clemastine—Fatigue—Estradiol—prostate cancer	0.000219	0.00144	CcSEcCtD
Clemastine—Constipation—Estradiol—prostate cancer	0.000217	0.00143	CcSEcCtD
Clemastine—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000217	0.00143	CcSEcCtD
Clemastine—Neuropathy peripheral—Prednisone—prostate cancer	0.000216	0.00143	CcSEcCtD
Clemastine—Vertigo—Etoposide—prostate cancer	0.000216	0.00142	CcSEcCtD
Clemastine—Paraesthesia—Mitoxantrone—prostate cancer	0.000212	0.0014	CcSEcCtD
Clemastine—Dizziness—Goserelin—prostate cancer	0.000212	0.00139	CcSEcCtD
Clemastine—Somnolence—Mitoxantrone—prostate cancer	0.00021	0.00138	CcSEcCtD
Clemastine—Dizziness—Conjugated Estrogens—prostate cancer	0.00021	0.00138	CcSEcCtD
Clemastine—Feeling abnormal—Estradiol—prostate cancer	0.000209	0.00138	CcSEcCtD
Clemastine—Convulsion—Etoposide—prostate cancer	0.000209	0.00137	CcSEcCtD
Clemastine—Dyspepsia—Mitoxantrone—prostate cancer	0.000208	0.00137	CcSEcCtD
Clemastine—Tinnitus—Capecitabine—prostate cancer	0.000208	0.00137	CcSEcCtD
Clemastine—Diplopia—Doxorubicin—prostate cancer	0.000207	0.00137	CcSEcCtD
Clemastine—Chills—Docetaxel—prostate cancer	0.000206	0.00136	CcSEcCtD
Clemastine—Decreased appetite—Mitoxantrone—prostate cancer	0.000205	0.00135	CcSEcCtD
Clemastine—Fatigue—Mitoxantrone—prostate cancer	0.000204	0.00134	CcSEcCtD
Clemastine—Vomiting—Goserelin—prostate cancer	0.000203	0.00134	CcSEcCtD
Clemastine—Constipation—Mitoxantrone—prostate cancer	0.000202	0.00133	CcSEcCtD
Clemastine—Vomiting—Conjugated Estrogens—prostate cancer	0.000201	0.00133	CcSEcCtD
Clemastine—Headache—Goserelin—prostate cancer	0.0002	0.00132	CcSEcCtD
Clemastine—Chills—Capecitabine—prostate cancer	0.0002	0.00131	CcSEcCtD
Clemastine—Headache—Conjugated Estrogens—prostate cancer	0.000198	0.00131	CcSEcCtD
Clemastine—Confusional state—Etoposide—prostate cancer	0.000198	0.0013	CcSEcCtD
Clemastine—Anaphylactic shock—Etoposide—prostate cancer	0.000197	0.00129	CcSEcCtD
Clemastine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000195	0.00128	CcSEcCtD
Clemastine—Thrombocytopenia—Etoposide—prostate cancer	0.000192	0.00127	CcSEcCtD
Clemastine—Tachycardia—Etoposide—prostate cancer	0.000192	0.00126	CcSEcCtD
Clemastine—Nausea—Goserelin—prostate cancer	0.00019	0.00125	CcSEcCtD
Clemastine—Hyperhidrosis—Etoposide—prostate cancer	0.00019	0.00125	CcSEcCtD
Clemastine—Nausea—Conjugated Estrogens—prostate cancer	0.000188	0.00124	CcSEcCtD
Clemastine—Anorexia—Etoposide—prostate cancer	0.000187	0.00123	CcSEcCtD
Clemastine—Hypotension—Etoposide—prostate cancer	0.000184	0.00121	CcSEcCtD
Clemastine—Vision blurred—Capecitabine—prostate cancer	0.000183	0.0012	CcSEcCtD
Clemastine—Asthenia—Estradiol—prostate cancer	0.000182	0.0012	CcSEcCtD
Clemastine—Tremor—Capecitabine—prostate cancer	0.000182	0.00119	CcSEcCtD
Clemastine—Pollakiuria—Epirubicin—prostate cancer	0.000179	0.00118	CcSEcCtD
Clemastine—Palpitations—Docetaxel—prostate cancer	0.000177	0.00116	CcSEcCtD
Clemastine—Photosensitivity reaction—Epirubicin—prostate cancer	0.000177	0.00116	CcSEcCtD
Clemastine—Paraesthesia—Etoposide—prostate cancer	0.000176	0.00116	CcSEcCtD
Clemastine—Somnolence—Etoposide—prostate cancer	0.000175	0.00115	CcSEcCtD
Clemastine—Vertigo—Capecitabine—prostate cancer	0.000174	0.00115	CcSEcCtD
Clemastine—Diarrhoea—Estradiol—prostate cancer	0.000174	0.00114	CcSEcCtD
Clemastine—Convulsion—Docetaxel—prostate cancer	0.000173	0.00114	CcSEcCtD
Clemastine—Drowsiness—Epirubicin—prostate cancer	0.000173	0.00114	CcSEcCtD
Clemastine—Palpitations—Capecitabine—prostate cancer	0.000171	0.00113	CcSEcCtD
Clemastine—Decreased appetite—Etoposide—prostate cancer	0.000171	0.00112	CcSEcCtD
Clemastine—Asthenia—Mitoxantrone—prostate cancer	0.00017	0.00112	CcSEcCtD
Clemastine—Fatigue—Etoposide—prostate cancer	0.000169	0.00112	CcSEcCtD
Clemastine—Neuropathy peripheral—Epirubicin—prostate cancer	0.000169	0.00111	CcSEcCtD
Clemastine—Constipation—Etoposide—prostate cancer	0.000168	0.00111	CcSEcCtD
Clemastine—Dizziness—Estradiol—prostate cancer	0.000168	0.0011	CcSEcCtD
Clemastine—Eletriptan—CYP3A4—prostate cancer	0.000168	0.0627	CrCbGaD
Clemastine—Pollakiuria—Doxorubicin—prostate cancer	0.000166	0.00109	CcSEcCtD
Clemastine—Confusional state—Docetaxel—prostate cancer	0.000165	0.00108	CcSEcCtD
Clemastine—Photosensitivity reaction—Doxorubicin—prostate cancer	0.000164	0.00108	CcSEcCtD
Clemastine—Anaphylactic shock—Docetaxel—prostate cancer	0.000163	0.00108	CcSEcCtD
Clemastine—Vision blurred—Prednisone—prostate cancer	0.000163	0.00107	CcSEcCtD
Clemastine—Feeling abnormal—Etoposide—prostate cancer	0.000162	0.00107	CcSEcCtD
Clemastine—Diarrhoea—Mitoxantrone—prostate cancer	0.000162	0.00106	CcSEcCtD
Clemastine—Vomiting—Estradiol—prostate cancer	0.000161	0.00106	CcSEcCtD
Clemastine—Agranulocytosis—Epirubicin—prostate cancer	0.000161	0.00106	CcSEcCtD
Clemastine—Thrombocytopenia—Docetaxel—prostate cancer	0.00016	0.00105	CcSEcCtD
Clemastine—Drowsiness—Doxorubicin—prostate cancer	0.00016	0.00105	CcSEcCtD
Clemastine—Confusional state—Capecitabine—prostate cancer	0.000159	0.00105	CcSEcCtD
Clemastine—Tachycardia—Docetaxel—prostate cancer	0.000159	0.00105	CcSEcCtD
Clemastine—Headache—Estradiol—prostate cancer	0.000159	0.00105	CcSEcCtD
Clemastine—Agitation—Prednisone—prostate cancer	0.000159	0.00104	CcSEcCtD
Clemastine—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000157	0.00103	CcSEcCtD
Clemastine—Anorexia—Docetaxel—prostate cancer	0.000156	0.00102	CcSEcCtD
Clemastine—Vertigo—Prednisone—prostate cancer	0.000155	0.00102	CcSEcCtD
Clemastine—Thrombocytopenia—Capecitabine—prostate cancer	0.000155	0.00102	CcSEcCtD
Clemastine—Tachycardia—Capecitabine—prostate cancer	0.000154	0.00102	CcSEcCtD
Clemastine—Hyperhidrosis—Capecitabine—prostate cancer	0.000153	0.00101	CcSEcCtD
Clemastine—Hypotension—Docetaxel—prostate cancer	0.000153	0.001	CcSEcCtD
Clemastine—Anorexia—Capecitabine—prostate cancer	0.000151	0.000992	CcSEcCtD
Clemastine—Nausea—Estradiol—prostate cancer	0.000151	0.000991	CcSEcCtD
Clemastine—Vomiting—Mitoxantrone—prostate cancer	0.00015	0.000989	CcSEcCtD
Clemastine—Convulsion—Prednisone—prostate cancer	0.00015	0.000984	CcSEcCtD
Clemastine—Agranulocytosis—Doxorubicin—prostate cancer	0.000149	0.000982	CcSEcCtD
Clemastine—Headache—Mitoxantrone—prostate cancer	0.000148	0.000974	CcSEcCtD
Clemastine—Hypotension—Capecitabine—prostate cancer	0.000148	0.000973	CcSEcCtD
Clemastine—Insomnia—Docetaxel—prostate cancer	0.000148	0.000972	CcSEcCtD
Clemastine—Paraesthesia—Docetaxel—prostate cancer	0.000147	0.000965	CcSEcCtD
Clemastine—Azelastine—CYP3A4—prostate cancer	0.000145	0.0543	CrCbGaD
Clemastine—Somnolence—Docetaxel—prostate cancer	0.000145	0.000956	CcSEcCtD
Clemastine—Tinnitus—Epirubicin—prostate cancer	0.000145	0.000952	CcSEcCtD
Clemastine—Dyspepsia—Docetaxel—prostate cancer	0.000144	0.000946	CcSEcCtD
Clemastine—Insomnia—Capecitabine—prostate cancer	0.000143	0.000941	CcSEcCtD
Clemastine—Paraesthesia—Capecitabine—prostate cancer	0.000142	0.000935	CcSEcCtD
Clemastine—Decreased appetite—Docetaxel—prostate cancer	0.000142	0.000935	CcSEcCtD
Clemastine—Asthenia—Etoposide—prostate cancer	0.000141	0.000928	CcSEcCtD
Clemastine—Anaphylactic shock—Prednisone—prostate cancer	0.000141	0.000927	CcSEcCtD
Clemastine—Fatigue—Docetaxel—prostate cancer	0.000141	0.000927	CcSEcCtD
Clemastine—Nausea—Mitoxantrone—prostate cancer	0.00014	0.000924	CcSEcCtD
Clemastine—Constipation—Docetaxel—prostate cancer	0.00014	0.000919	CcSEcCtD
Clemastine—Dyspepsia—Capecitabine—prostate cancer	0.000139	0.000916	CcSEcCtD
Clemastine—Chills—Epirubicin—prostate cancer	0.000139	0.000916	CcSEcCtD
Clemastine—Tachycardia—Prednisone—prostate cancer	0.000137	0.000905	CcSEcCtD
Clemastine—Decreased appetite—Capecitabine—prostate cancer	0.000137	0.000905	CcSEcCtD
Clemastine—Fatigue—Capecitabine—prostate cancer	0.000136	0.000897	CcSEcCtD
Clemastine—Hyperhidrosis—Prednisone—prostate cancer	0.000136	0.000896	CcSEcCtD
Clemastine—Constipation—Capecitabine—prostate cancer	0.000135	0.00089	CcSEcCtD
Clemastine—Feeling abnormal—Docetaxel—prostate cancer	0.000135	0.000886	CcSEcCtD
Clemastine—Diarrhoea—Etoposide—prostate cancer	0.000134	0.000885	CcSEcCtD
Clemastine—Anorexia—Prednisone—prostate cancer	0.000134	0.000884	CcSEcCtD
Clemastine—Tinnitus—Doxorubicin—prostate cancer	0.000134	0.000881	CcSEcCtD
Clemastine—Thioridazine—CYP2E1—prostate cancer	0.000134	0.05	CrCbGaD
Clemastine—Tension—Epirubicin—prostate cancer	0.000132	0.000872	CcSEcCtD
Clemastine—Thioridazine—CYP2C19—prostate cancer	0.000132	0.0495	CrCbGaD
Clemastine—Nervousness—Epirubicin—prostate cancer	0.000131	0.000863	CcSEcCtD
Clemastine—Feeling abnormal—Capecitabine—prostate cancer	0.00013	0.000858	CcSEcCtD
Clemastine—Dizziness—Etoposide—prostate cancer	0.00013	0.000855	CcSEcCtD
Clemastine—Chills—Doxorubicin—prostate cancer	0.000129	0.000847	CcSEcCtD
Clemastine—Insomnia—Prednisone—prostate cancer	0.000127	0.000839	CcSEcCtD
Clemastine—Vision blurred—Epirubicin—prostate cancer	0.000127	0.000837	CcSEcCtD
Clemastine—Paraesthesia—Prednisone—prostate cancer	0.000126	0.000833	CcSEcCtD
Clemastine—Vomiting—Etoposide—prostate cancer	0.000125	0.000823	CcSEcCtD
Clemastine—Agitation—Epirubicin—prostate cancer	0.000124	0.000817	CcSEcCtD
Clemastine—Dyspepsia—Prednisone—prostate cancer	0.000124	0.000816	CcSEcCtD
Clemastine—Headache—Etoposide—prostate cancer	0.000123	0.00081	CcSEcCtD
Clemastine—Tension—Doxorubicin—prostate cancer	0.000123	0.000807	CcSEcCtD
Clemastine—Decreased appetite—Prednisone—prostate cancer	0.000122	0.000806	CcSEcCtD
Clemastine—Fatigue—Prednisone—prostate cancer	0.000121	0.000799	CcSEcCtD
Clemastine—Nervousness—Doxorubicin—prostate cancer	0.000121	0.000798	CcSEcCtD
Clemastine—Vertigo—Epirubicin—prostate cancer	0.000121	0.000798	CcSEcCtD
Clemastine—Constipation—Prednisone—prostate cancer	0.00012	0.000793	CcSEcCtD
Clemastine—Palpitations—Epirubicin—prostate cancer	0.000119	0.000785	CcSEcCtD
Clemastine—Vision blurred—Doxorubicin—prostate cancer	0.000118	0.000775	CcSEcCtD
Clemastine—Asthenia—Docetaxel—prostate cancer	0.000117	0.000771	CcSEcCtD
Clemastine—Convulsion—Epirubicin—prostate cancer	0.000117	0.00077	CcSEcCtD
Clemastine—Nausea—Etoposide—prostate cancer	0.000117	0.000768	CcSEcCtD
Clemastine—Feeling abnormal—Prednisone—prostate cancer	0.000116	0.000764	CcSEcCtD
Clemastine—Agitation—Doxorubicin—prostate cancer	0.000115	0.000756	CcSEcCtD
Clemastine—Asthenia—Capecitabine—prostate cancer	0.000113	0.000747	CcSEcCtD
Clemastine—Vertigo—Doxorubicin—prostate cancer	0.000112	0.000739	CcSEcCtD
Clemastine—Diarrhoea—Docetaxel—prostate cancer	0.000112	0.000736	CcSEcCtD
Clemastine—Confusional state—Epirubicin—prostate cancer	0.000111	0.000731	CcSEcCtD
Clemastine—Palpitations—Doxorubicin—prostate cancer	0.00011	0.000727	CcSEcCtD
Clemastine—Anaphylactic shock—Epirubicin—prostate cancer	0.00011	0.000725	CcSEcCtD
Clemastine—Loperamide—CYP3A4—prostate cancer	0.000109	0.0409	CrCbGaD
Clemastine—Convulsion—Doxorubicin—prostate cancer	0.000108	0.000712	CcSEcCtD
Clemastine—Diarrhoea—Capecitabine—prostate cancer	0.000108	0.000712	CcSEcCtD
Clemastine—Dizziness—Docetaxel—prostate cancer	0.000108	0.000711	CcSEcCtD
Clemastine—Thrombocytopenia—Epirubicin—prostate cancer	0.000108	0.00071	CcSEcCtD
Clemastine—Tachycardia—Epirubicin—prostate cancer	0.000108	0.000708	CcSEcCtD
Clemastine—Hyperhidrosis—Epirubicin—prostate cancer	0.000107	0.000701	CcSEcCtD
Clemastine—Anorexia—Epirubicin—prostate cancer	0.000105	0.000691	CcSEcCtD
Clemastine—Dizziness—Capecitabine—prostate cancer	0.000105	0.000688	CcSEcCtD
Clemastine—Vomiting—Docetaxel—prostate cancer	0.000104	0.000684	CcSEcCtD
Clemastine—Hypotension—Epirubicin—prostate cancer	0.000103	0.000678	CcSEcCtD
Clemastine—Confusional state—Doxorubicin—prostate cancer	0.000103	0.000677	CcSEcCtD
Clemastine—Headache—Docetaxel—prostate cancer	0.000102	0.000674	CcSEcCtD
Clemastine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000102	0.000671	CcSEcCtD
Clemastine—Asthenia—Prednisone—prostate cancer	0.000101	0.000665	CcSEcCtD
Clemastine—Vomiting—Capecitabine—prostate cancer	0.000101	0.000662	CcSEcCtD
Clemastine—Thrombocytopenia—Doxorubicin—prostate cancer	9.98e-05	0.000657	CcSEcCtD
Clemastine—Insomnia—Epirubicin—prostate cancer	9.96e-05	0.000656	CcSEcCtD
Clemastine—Tachycardia—Doxorubicin—prostate cancer	9.95e-05	0.000655	CcSEcCtD
Clemastine—Headache—Capecitabine—prostate cancer	9.91e-05	0.000652	CcSEcCtD
Clemastine—Paraesthesia—Epirubicin—prostate cancer	9.89e-05	0.000651	CcSEcCtD
Clemastine—Hyperhidrosis—Doxorubicin—prostate cancer	9.85e-05	0.000649	CcSEcCtD
Clemastine—Somnolence—Epirubicin—prostate cancer	9.79e-05	0.000645	CcSEcCtD
Clemastine—Anorexia—Doxorubicin—prostate cancer	9.72e-05	0.00064	CcSEcCtD
Clemastine—Nausea—Docetaxel—prostate cancer	9.7e-05	0.000639	CcSEcCtD
Clemastine—Dyspepsia—Epirubicin—prostate cancer	9.7e-05	0.000638	CcSEcCtD
Clemastine—Diarrhoea—Prednisone—prostate cancer	9.64e-05	0.000634	CcSEcCtD
Clemastine—Decreased appetite—Epirubicin—prostate cancer	9.58e-05	0.00063	CcSEcCtD
Clemastine—Hypotension—Doxorubicin—prostate cancer	9.53e-05	0.000627	CcSEcCtD
Clemastine—Fatigue—Epirubicin—prostate cancer	9.5e-05	0.000625	CcSEcCtD
Clemastine—Constipation—Epirubicin—prostate cancer	9.42e-05	0.00062	CcSEcCtD
Clemastine—Nausea—Capecitabine—prostate cancer	9.39e-05	0.000618	CcSEcCtD
Clemastine—Dizziness—Prednisone—prostate cancer	9.31e-05	0.000613	CcSEcCtD
Clemastine—Insomnia—Doxorubicin—prostate cancer	9.22e-05	0.000607	CcSEcCtD
Clemastine—Paraesthesia—Doxorubicin—prostate cancer	9.15e-05	0.000602	CcSEcCtD
Clemastine—Feeling abnormal—Epirubicin—prostate cancer	9.08e-05	0.000598	CcSEcCtD
Clemastine—Somnolence—Doxorubicin—prostate cancer	9.06e-05	0.000596	CcSEcCtD
Clemastine—Dyspepsia—Doxorubicin—prostate cancer	8.97e-05	0.000591	CcSEcCtD
Clemastine—Vomiting—Prednisone—prostate cancer	8.96e-05	0.00059	CcSEcCtD
Clemastine—Decreased appetite—Doxorubicin—prostate cancer	8.86e-05	0.000583	CcSEcCtD
Clemastine—Headache—Prednisone—prostate cancer	8.82e-05	0.000581	CcSEcCtD
Clemastine—Fatigue—Doxorubicin—prostate cancer	8.79e-05	0.000578	CcSEcCtD
Clemastine—Constipation—Doxorubicin—prostate cancer	8.72e-05	0.000574	CcSEcCtD
Clemastine—Feeling abnormal—Doxorubicin—prostate cancer	8.4e-05	0.000553	CcSEcCtD
Clemastine—Nausea—Prednisone—prostate cancer	8.37e-05	0.000551	CcSEcCtD
Clemastine—Asthenia—Epirubicin—prostate cancer	7.9e-05	0.00052	CcSEcCtD
Clemastine—Diarrhoea—Epirubicin—prostate cancer	7.54e-05	0.000496	CcSEcCtD
Clemastine—Asthenia—Doxorubicin—prostate cancer	7.31e-05	0.000481	CcSEcCtD
Clemastine—Dizziness—Epirubicin—prostate cancer	7.29e-05	0.00048	CcSEcCtD
Clemastine—Vomiting—Epirubicin—prostate cancer	7e-05	0.000461	CcSEcCtD
Clemastine—Diarrhoea—Doxorubicin—prostate cancer	6.97e-05	0.000459	CcSEcCtD
Clemastine—Headache—Epirubicin—prostate cancer	6.9e-05	0.000454	CcSEcCtD
Clemastine—Dizziness—Doxorubicin—prostate cancer	6.74e-05	0.000444	CcSEcCtD
Clemastine—Nausea—Epirubicin—prostate cancer	6.54e-05	0.000431	CcSEcCtD
Clemastine—Vomiting—Doxorubicin—prostate cancer	6.48e-05	0.000427	CcSEcCtD
Clemastine—Headache—Doxorubicin—prostate cancer	6.39e-05	0.00042	CcSEcCtD
Clemastine—Nausea—Doxorubicin—prostate cancer	6.05e-05	0.000399	CcSEcCtD
Clemastine—CYP3A4—Metabolism—RFK—prostate cancer	1.75e-05	0.000272	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.75e-05	0.000272	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NAGLU—prostate cancer	1.75e-05	0.000272	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—HIST1H4H—prostate cancer	1.75e-05	0.000271	CbGpPWpGaD
Clemastine—HRH1—GPCR ligand binding—CXCL8—prostate cancer	1.75e-05	0.000271	CbGpPWpGaD
Clemastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	1.74e-05	0.00027	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—LDHB—prostate cancer	1.73e-05	0.000268	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GNG5—prostate cancer	1.71e-05	0.000265	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP3A5—prostate cancer	1.7e-05	0.000263	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.66e-05	0.000258	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—AMACR—prostate cancer	1.66e-05	0.000258	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NAT1—prostate cancer	1.66e-05	0.000258	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—DEGS1—prostate cancer	1.66e-05	0.000258	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.66e-05	0.000258	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PDHA1—prostate cancer	1.64e-05	0.000254	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—TCN2—prostate cancer	1.64e-05	0.000254	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—UCP3—prostate cancer	1.64e-05	0.000254	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTA3—prostate cancer	1.64e-05	0.000254	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.59e-05	0.000246	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—HSD3B1—prostate cancer	1.56e-05	0.000242	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—SLC22A3—prostate cancer	1.56e-05	0.000242	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—TBXAS1—prostate cancer	1.5e-05	0.000232	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTA4—prostate cancer	1.5e-05	0.000232	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PTHLH—prostate cancer	1.49e-05	0.000231	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—TGFBR1—prostate cancer	1.49e-05	0.000231	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—AKR1C3—prostate cancer	1.46e-05	0.000227	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTA2—prostate cancer	1.46e-05	0.000227	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PRKACB—prostate cancer	1.45e-05	0.000226	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ABCG5—prostate cancer	1.44e-05	0.000224	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—SULT1A1—prostate cancer	1.44e-05	0.000224	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—THBS1—prostate cancer	1.42e-05	0.00022	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PPP3CA—prostate cancer	1.42e-05	0.00022	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—HPGD—prostate cancer	1.41e-05	0.000219	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.41e-05	0.000219	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTA1—prostate cancer	1.41e-05	0.000219	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ANXA1—prostate cancer	1.4e-05	0.000217	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—HSD3B2—prostate cancer	1.39e-05	0.000216	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NAT2—prostate cancer	1.39e-05	0.000216	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTO1—prostate cancer	1.39e-05	0.000216	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PRKCZ—prostate cancer	1.37e-05	0.000213	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PIK3CG—prostate cancer	1.34e-05	0.000208	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PLCB2—prostate cancer	1.34e-05	0.000207	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP2C18—prostate cancer	1.34e-05	0.000207	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—LRP2—prostate cancer	1.34e-05	0.000207	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.33e-05	0.000206	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PARP1—prostate cancer	1.32e-05	0.000205	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FGFR4—prostate cancer	1.32e-05	0.000205	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—P4HB—prostate cancer	1.31e-05	0.000203	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CALCA—prostate cancer	1.31e-05	0.000203	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.29e-05	0.000201	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—MTAP—prostate cancer	1.29e-05	0.000201	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CXCL12—prostate cancer	1.28e-05	0.000198	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—SLC22A1—prostate cancer	1.27e-05	0.000198	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.26e-05	0.000195	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.26e-05	0.000195	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—SULT2A1—prostate cancer	1.24e-05	0.000193	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—MED12—prostate cancer	1.22e-05	0.00019	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PIK3CG—prostate cancer	1.22e-05	0.000189	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GNG5—prostate cancer	1.21e-05	0.000188	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CASP9—prostate cancer	1.2e-05	0.000187	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ACSL4—prostate cancer	1.2e-05	0.000186	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.2e-05	0.000186	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PIK3CD—prostate cancer	1.18e-05	0.000183	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NCOA3—prostate cancer	1.17e-05	0.000181	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PRKCQ—prostate cancer	1.17e-05	0.000181	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—NGFR—prostate cancer	1.17e-05	0.000181	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PHGDH—prostate cancer	1.15e-05	0.000179	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—UMPS—prostate cancer	1.15e-05	0.000179	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ARG2—prostate cancer	1.15e-05	0.000179	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—MAP3K7—prostate cancer	1.15e-05	0.000179	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—LDHB—prostate cancer	1.13e-05	0.000175	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—HPGDS—prostate cancer	1.11e-05	0.000173	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP3A5—prostate cancer	1.11e-05	0.000172	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FGF10—prostate cancer	1.11e-05	0.000172	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP2C19—prostate cancer	1.11e-05	0.000172	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ADRB2—prostate cancer	1.1e-05	0.00017	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—JAK2—prostate cancer	1.08e-05	0.000168	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ACHE—prostate cancer	1.08e-05	0.000168	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTT1—prostate cancer	1.08e-05	0.000168	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—MAP2K1—prostate cancer	1.08e-05	0.000167	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PDHA1—prostate cancer	1.07e-05	0.000166	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—TCN2—prostate cancer	1.07e-05	0.000166	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—UCP3—prostate cancer	1.07e-05	0.000166	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTA3—prostate cancer	1.07e-05	0.000166	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PIK3CD—prostate cancer	1.07e-05	0.000166	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—VAV3—prostate cancer	1.07e-05	0.000166	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP2A6—prostate cancer	1.07e-05	0.000166	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—TGFBR2—prostate cancer	1.05e-05	0.000163	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—AKR1C3—prostate cancer	1.04e-05	0.000161	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ITPR1—prostate cancer	1.04e-05	0.000161	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PRKACB—prostate cancer	1.03e-05	0.00016	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PIK3CB—prostate cancer	1.03e-05	0.000159	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP17A1—prostate cancer	1.02e-05	0.000159	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SLC22A3—prostate cancer	1.02e-05	0.000159	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—HSD3B1—prostate cancer	1.02e-05	0.000159	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IGF1R—prostate cancer	9.91e-06	0.000154	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—CXCL8—prostate cancer	9.87e-06	0.000153	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—JAK2—prostate cancer	9.82e-06	0.000152	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—TBXAS1—prostate cancer	9.79e-06	0.000152	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTA4—prostate cancer	9.79e-06	0.000152	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NCOA2—prostate cancer	9.74e-06	0.000151	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTA2—prostate cancer	9.54e-06	0.000148	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—LPL—prostate cancer	9.5e-06	0.000147	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—IL2—prostate cancer	9.43e-06	0.000146	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SULT1A1—prostate cancer	9.43e-06	0.000146	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ABCG5—prostate cancer	9.43e-06	0.000146	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PDGFRB—prostate cancer	9.42e-06	0.000146	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PIK3CB—prostate cancer	9.32e-06	0.000145	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—SLC5A5—prostate cancer	9.29e-06	0.000144	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTA1—prostate cancer	9.21e-06	0.000143	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ITGB3—prostate cancer	9.18e-06	0.000142	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—HSD3B2—prostate cancer	9.11e-06	0.000141	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTO1—prostate cancer	9.11e-06	0.000141	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NAT2—prostate cancer	9.11e-06	0.000141	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP2E1—prostate cancer	9.08e-06	0.000141	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NQO1—prostate cancer	8.97e-06	0.000139	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—CXCL8—prostate cancer	8.96e-06	0.000139	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ERBB3—prostate cancer	8.9e-06	0.000138	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FGFR2—prostate cancer	8.89e-06	0.000138	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—TH—prostate cancer	8.84e-06	0.000137	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP3A4—prostate cancer	8.75e-06	0.000136	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PLCB2—prostate cancer	8.73e-06	0.000135	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP2C18—prostate cancer	8.73e-06	0.000135	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—LRP2—prostate cancer	8.73e-06	0.000135	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP1B1—prostate cancer	8.6e-06	0.000134	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—IL2—prostate cancer	8.56e-06	0.000133	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—P4HB—prostate cancer	8.56e-06	0.000133	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—TERT—prostate cancer	8.53e-06	0.000132	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GGT1—prostate cancer	8.33e-06	0.000129	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SLC22A1—prostate cancer	8.33e-06	0.000129	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NCOA1—prostate cancer	8.21e-06	0.000127	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—HIF1A—prostate cancer	8.16e-06	0.000127	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SULT2A1—prostate cancer	8.12e-06	0.000126	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP19A1—prostate cancer	8.09e-06	0.000126	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—MED12—prostate cancer	7.98e-06	0.000124	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—LEP—prostate cancer	7.97e-06	0.000124	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GNG5—prostate cancer	7.92e-06	0.000123	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CAV1—prostate cancer	7.89e-06	0.000122	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—RXRA—prostate cancer	7.81e-06	0.000121	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—KDR—prostate cancer	7.8e-06	0.000121	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NCOA3—prostate cancer	7.63e-06	0.000118	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ESR1—prostate cancer	7.6e-06	0.000118	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—COMT—prostate cancer	7.52e-06	0.000117	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTP1—prostate cancer	7.49e-06	0.000116	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—BAD—prostate cancer	7.42e-06	0.000115	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ITPR1—prostate cancer	7.37e-06	0.000114	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—HPGDS—prostate cancer	7.28e-06	0.000113	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP2C19—prostate cancer	7.23e-06	0.000112	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PIK3CG—prostate cancer	7.19e-06	0.000112	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—APC—prostate cancer	7.19e-06	0.000112	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IRS1—prostate cancer	7.11e-06	0.00011	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—EGF—prostate cancer	7.11e-06	0.00011	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ACHE—prostate cancer	7.06e-06	0.00011	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTT1—prostate cancer	7.06e-06	0.00011	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP2A6—prostate cancer	6.98e-06	0.000108	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—TYMS—prostate cancer	6.96e-06	0.000108	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—GSK3B—prostate cancer	6.9e-06	0.000107	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—GSTM1—prostate cancer	6.88e-06	0.000107	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—INS—prostate cancer	6.8e-06	0.000106	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—AKR1C3—prostate cancer	6.79e-06	0.000105	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PRKACB—prostate cancer	6.75e-06	0.000105	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—LPL—prostate cancer	6.75e-06	0.000105	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP17A1—prostate cancer	6.68e-06	0.000104	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CREBBP—prostate cancer	6.66e-06	0.000103	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IGF1—prostate cancer	6.58e-06	0.000102	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—EGFR—prostate cancer	6.55e-06	0.000102	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CYP1A1—prostate cancer	6.52e-06	0.000101	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—ERCC2—prostate cancer	6.47e-06	0.0001	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NCOA2—prostate cancer	6.37e-06	9.88e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—MAP2K1—prostate cancer	6.36e-06	9.87e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PIK3CD—prostate cancer	6.32e-06	9.81e-05	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	6.26e-06	9.71e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—SERPINE1—prostate cancer	6.25e-06	9.7e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—KRAS—prostate cancer	6.19e-06	9.6e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—MTHFR—prostate cancer	6.08e-06	9.43e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—SLC5A5—prostate cancer	6.08e-06	9.43e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—FGF2—prostate cancer	6.05e-06	9.39e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—NOS3—prostate cancer	5.97e-06	9.26e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PPARA—prostate cancer	5.96e-06	9.26e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.93e-06	9.21e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NQO1—prostate cancer	5.87e-06	9.11e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—JAK2—prostate cancer	5.8e-06	9e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—TH—prostate cancer	5.78e-06	8.97e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	5.68e-06	8.82e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—MDM2—prostate cancer	5.66e-06	8.79e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP1B1—prostate cancer	5.63e-06	8.73e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CAV1—prostate cancer	5.61e-06	8.7e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—ERBB2—prostate cancer	5.58e-06	8.66e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	5.51e-06	8.55e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GGT1—prostate cancer	5.45e-06	8.46e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NCOA1—prostate cancer	5.37e-06	8.33e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CXCL8—prostate cancer	5.29e-06	8.21e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP19A1—prostate cancer	5.29e-06	8.21e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	5.17e-06	8.02e-05	CbGpPWpGaD
Clemastine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	5.11e-06	7.94e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PIK3CG—prostate cancer	5.11e-06	7.93e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—RXRA—prostate cancer	5.1e-06	7.92e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CASP3—prostate cancer	5.07e-06	7.86e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IL2—prostate cancer	5.06e-06	7.85e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—IL6—prostate cancer	5.03e-06	7.81e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CCND1—prostate cancer	4.93e-06	7.65e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—COMT—prostate cancer	4.92e-06	7.63e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTP1—prostate cancer	4.89e-06	7.59e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	4.88e-06	7.58e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—INS—prostate cancer	4.83e-06	7.5e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ITPR1—prostate cancer	4.82e-06	7.47e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—MMP9—prostate cancer	4.79e-06	7.43e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	4.77e-06	7.4e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PTEN—prostate cancer	4.76e-06	7.39e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—CREBBP—prostate cancer	4.74e-06	7.35e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling by GPCR—AKT1—prostate cancer	4.64e-06	7.21e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—TYMS—prostate cancer	4.55e-06	7.06e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—EP300—prostate cancer	4.54e-06	7.04e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—GSTM1—prostate cancer	4.5e-06	6.98e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PIK3CD—prostate cancer	4.49e-06	6.97e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—LPL—prostate cancer	4.41e-06	6.85e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—SRC—prostate cancer	4.41e-06	6.85e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—VEGFA—prostate cancer	4.3e-06	6.67e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CYP1A1—prostate cancer	4.26e-06	6.62e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—STAT3—prostate cancer	4.26e-06	6.61e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—NOS3—prostate cancer	4.24e-06	6.58e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—ERCC2—prostate cancer	4.23e-06	6.56e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—MTHFR—prostate cancer	3.97e-06	6.17e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—MYC—prostate cancer	3.96e-06	6.14e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—TGFB1—prostate cancer	3.95e-06	6.12e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PIK3CB—prostate cancer	3.91e-06	6.07e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PPARA—prostate cancer	3.9e-06	6.05e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PTGS2—prostate cancer	3.88e-06	6.02e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—EGFR—prostate cancer	3.87e-06	6e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CAV1—prostate cancer	3.67e-06	5.69e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—KRAS—prostate cancer	3.65e-06	5.67e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PTEN—prostate cancer	3.38e-06	5.25e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	3.36e-06	5.21e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PIK3CG—prostate cancer	3.34e-06	5.18e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—TP53—prostate cancer	3.25e-06	5.04e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—EP300—prostate cancer	3.23e-06	5.01e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—INS—prostate cancer	3.16e-06	4.91e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—CREBBP—prostate cancer	3.1e-06	4.8e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—IL6—prostate cancer	2.97e-06	4.61e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.94e-06	4.56e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—NOS3—prostate cancer	2.77e-06	4.3e-05	CbGpPWpGaD
Clemastine—HRH1—Signaling Pathways—AKT1—prostate cancer	2.74e-06	4.26e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.56e-06	3.97e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PTGS2—prostate cancer	2.54e-06	3.93e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—PIK3CA—prostate cancer	2.39e-06	3.7e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PTEN—prostate cancer	2.21e-06	3.43e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—EP300—prostate cancer	2.11e-06	3.27e-05	CbGpPWpGaD
Clemastine—CYP2D6—Metabolism—AKT1—prostate cancer	1.95e-06	3.02e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.56e-06	2.42e-05	CbGpPWpGaD
Clemastine—CYP3A4—Metabolism—AKT1—prostate cancer	1.27e-06	1.98e-05	CbGpPWpGaD
